Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Dr. Reddy's Laboratories Ltd (RDY) had Return on Tangible Equity of -0.37% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$593.01M |
|
$-10.78M |
|
$349.85M |
|
$243.16M |
|
$619.88M |
|
$-26.86M |
|
$4.04M |
|
$-22.83M |
|
$-22.83M |
|
$-10.32M |
|
$-10.32M |
|
$-10.32M |
|
$-10.32M |
|
$-26.87M |
|
$26.14M |
|
832.44M |
|
833.33M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$3.22B |
|
$1.24B |
|
$2.96B |
|
$6.17B |
|
$1.79B |
|
$130.00M |
|
$334.00M |
|
$2.12B |
|
$4.05B |
|
$2.80B |
|
$4.05B |
|
834.66M |
|
| Cash Flow Statement Financials | |
$607.00M |
|
$-700.00M |
|
$88.00M |
|
$156.00M |
|
$164.00M |
|
$8.00M |
|
$3.00M |
|
$-71.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.80 |
|
-- |
|
-- |
|
0.03 |
|
0.20 |
|
41.00% |
|
-4.53% |
|
-4.53% |
|
-- |
|
-3.85% |
|
-1.82% |
|
$361.00M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.43 |
|
0.55 |
|
163.76 |
|
-0.25% |
|
|
Return on Tangible Equity |
-0.37% |
-0.17% |
|
-0.25% |
|
$4.86 |
|
$0.43 |
|
$0.73 |
|